共 50 条
- [41] Safety and efficacy of mass drug administration with a single-dose triple-drug regimen of albendazole plus diethylcarbamazine plus ivermectin for lymphatic filariasis in Papua New Guinea: An open-label, cluster-randomised trial [J]. PLOS NEGLECTED TROPICAL DISEASES, 2022, 16 (02):
- [42] THE RELATIVE SAFETY OF A PROMISING TRIPLE DRUG MASS DRUG ADMINISTRATION REGIMEN VERSUS A TWO-DRUG REGIMEN FOR LYMPHATIC FILARIASIS ELIMINATION IN INDIA [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2018, 99 (04): : 614 - 614
- [44] Pharmacokinetics, safety, and efficacy of a single co-administered dose of diethylcarbamazine, albendazole and ivermectin in adults with and without Wuchereria bancrofti infection in Cote d'Ivoire [J]. PLOS NEGLECTED TROPICAL DISEASES, 2019, 13 (05):
- [45] Country Reports on Practical Aspects of Conducting Large-Scale Community Studies of the Tolerability of Mass Drug Administration with Ivermectin/Diethylcarbamazine/Albendazole for Lymphatic Filariasis [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2022, 106 (05): : 18 - 25
- [46] IMPROVING COMMUNITY VOLUNTEER ENGAGEMENT AND IMPLEMENTATION OF MASS DRUG ADMINISTRATION FOR LYMPHATIC FILARIASIS THROUGH MICROPLANNING: A CASE STUDY OF PORT-AU-PRINCE, HAITI [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2018, 99 (04): : 170 - 170
- [47] The roles of stakeholder experience and organizational learning in declining mass drug administration coverage for lymphatic filariasis in Port-au-Prince, Haiti: A case study [J]. PLOS NEGLECTED TROPICAL DISEASES, 2020, 14 (05): : 1 - 18
- [48] LESSONS FROM LYMPHATIC FILARIASIS TRANSMISSION INTERRUPTION IN HAITI: ARE FIVE ROUNDS OF ANNUAL MASS DRUG ADMINISTRATION (MDA) NECESSARY IN LOW-PREVALENCE SETTINGS? [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 95 (05): : 155 - 156